Valle Morales
Charterhouse Square
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A novel inhibitor of soluble epoxide hydrolase that adducts C521 is cardioprotective.
Journal: Redox biology
Published: December 05, 2025
Publisher Correction: The glucose transporter 2 regulates CD8+ T cell function via environment sensing.
Journal: Nature metabolism
Published: February 25, 2025
Metabolic remodeling in hiPSC-derived myofibers carrying the m.3243A>G mutation.
Journal: Stem cell reports
Published: December 18, 2024
Altered Cellular Metabolism Is a Consequence of Loss of the Ataxia-Linked Protein Sacsin.
Journal: International journal of molecular sciences
Published: November 04, 2024
New Model of Experimental Diabetic Cardiomyopathy Using Combination of Multiple Doses of Anomer-Equilibrated Streptozotocin and High-Fat Diet: Sex Matters.
Journal: Diabetes
Published: May 08, 2024
Overcoming resistance to arginine deprivation therapy using GC7 in pleural mesothelioma.
Journal: iScience
Published: April 18, 2024
Pyruvate metabolism dictates fibroblast sensitivity to GLS1 inhibition during fibrogenesis.
Journal: JCI insight
Published: December 13, 2023
Myocardial alterations following traumatic hemorrhagic injury.
Journal: The journal of trauma and acute care surgery
Published: May 30, 2023
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2.
Journal: EMBO molecular medicine
Published: April 04, 2023
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia.
Journal: Science translational medicine
Published: March 01, 2023
The glucose transporter 2 regulates CD8+ T cell function via environment sensing.
Journal: Nature metabolism
Published: October 21, 2022
Last Updated: 09/26/2026